William Wierda, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the importance of genomic testing in chronic lymphocytic leukemia (CLL), and further highlights various methods used in the prognosis and diagnosis of patients. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
